Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy

BACKGROUND/AIMS: The ability of endoscopic submucosal dissection (ESD) to resect large early gastric cancers (EGCs) results in the need to treat large artificial gastric ulcers. This study assessed whether the combination therapy of rebamipide plus a proton pump inhibitor (PPI) offered benefits over...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Kazuhiko, Ihara, Eikichi, Akiho, Hirotada, Akahoshi, Kazuya, Harada, Naohiko, Ochiai, Toshiaki, Nakamura, Norimoto, Ogino, Haruei, Iwasa, Tsutomu, Aso, Akira, Iboshi, Yoichiro, Takayanagi, Ryoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087931/
https://www.ncbi.nlm.nih.gov/pubmed/27282261
http://dx.doi.org/10.5009/gnl15486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087931/
https://www.ncbi.nlm.nih.gov/pubmed/27282261
http://dx.doi.org/10.5009/gnl15486

Ejemplares similares